Oxymorphone Hydrochloride

Oxymorphone Hydrochloride

Cat Number
API357073
CAS Number
357-07-3

If you have any other questions, please contact our experts.

CAS Number
357-07-3
Synonyms
Oxymorphone HCl
Molecular Formula
C17H20ClNO4
Molecular Weight
337.8
Smiles
CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O.Cl
Appearance
Crystalline solid
General Description
Oxymorphone Hydrochloride is a semi-synthetic opioid analgesic derived from thebaine. It is structurally related to morphine but possesses significantly greater analgesic potency.
Mechanism of Action
Oxymorphone agonizes mu-opioid receptors in the central nervous system, activating G-protein-coupled signaling that inhibits adenylate cyclase, closes voltage-gated calcium channels, and opens potassium channels, reducing neuronal excitability and pain transmission.
Application
Used in the management of moderate to severe pain. Oxymorphone Hydrochloride is indicated for acute postoperative pain, cancer pain, and chronic severe pain requiring opioid management.

Oxymorphone is a typical mu-opioid agonist that is effective in both immediate-release and extended-release oral formulations. The mechanism of action involves binding to mu-opioid receptors in the central nervous system, where it alters the perception of and response to painful stimuli while producing generalized central nervous system depression. Oxymorphone is more lipid soluble than morphine, resulting in a rapid onset of action when given in tablet formulation, with a duration of action of approximately 4-6 hours in immediate-release and 12 hours in extended-release preparations. Oral oxymorphone provides excellent pain relief for significant pain including acute postoperative pain, chronic arthritis pain, chronic low back pain, and chronic cancer pain. Multiple double-blind, prospective, placebo-controlled clinical trials have demonstrated the clinical efficacy and safety of this oral opioid formulation.

Fig. 1 Mean single-dose and steady-state plasma concentrations of oxymorphone IR. (Sloan P. 2008) Fig. 1 Mean single-dose and steady-state plasma concentrations of oxymorphone IR. (Sloan P. 2008)

References

  1. Sloan P. Review of oral oxymorphone in the management of pain. Therapeutics and Clinical Risk Management, 2008, 4(4): 777-787.

What distinguishes Oxymorphone from morphine in pain management?

Oxymorphone provides approximately ten times the analgesic potency of morphine, allowing effective pain control at lower doses with a different metabolic profile.

What is the minimum order quantity (MOQ)?

Flexible MOQ options are available to support both early-stage research and large-scale manufacturing needs.

What purity grade is available?

It is supplied as a high-purity grade suitable for R&D and pharmaceutical manufacturing.

Can packaging and order quantities be customized?

Yes, both packaging formats and order quantities can be tailored to meet specific R&D and production needs.
You Might Also Like
Thiamphenicol
Thiamphenicol

Cat NO.: API15318453
CAS NO.: 15318-45-3

View Details
Trametinib
Trametinib

Cat NO.: API871700173
CAS NO.: 871700-17-3

View Details
Atorvastatin acetonide tert-butyl ester
Atorvastatin acetonide tert-butyl ester

Cat NO.: API125971951
CAS NO.: 125971-95-1

View Details
Bupropion Hydrobromide
Bupropion Hydrobromide

Cat NO.: API0232137
CAS NO.: 905818-69-1

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top